ALIGN TECHNOLOGY, INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
ALIGN TECHNOLOGY, INC. (ALGN) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-02-28
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2018 was $0.00.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $16.77M, a 61.34% increase from fiscal 2015.
- ALIGN TECHNOLOGY, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $10.40M, a 51.40% decline from fiscal 2014.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | $2.83M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $2.83M derived: sum of 3 quarters · filed 2019-02-28 | $6.08M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $2.83M derived: sum of 2 quarters · filed 2019-02-28 | $6.08M derived: sum of 3 quarters · filed 2019-02-28 | $8.69M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $6.08M derived: sum of 2 quarters · filed 2019-02-28 | $8.69M derived: sum of 3 quarters · filed 2019-02-28 | $16.77M 10-K · filed 2019-02-28 |
| 2016-09-30 | $3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $5.86M derived: sum of 2 quarters · filed 2017-11-02 | $13.94M 10-Q · filed 2017-11-02 | $15.68M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $10.70M 10-Q · filed 2017-08-03 | $12.43M derived: sum of 3 quarters · filed 2018-02-28 | $14.89M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $8.08M 10-Q · filed 2017-05-04 | $9.81M derived: sum of 2 quarters · filed 2018-02-28 | $12.27M derived: sum of 3 quarters · filed 2018-02-28 | $13.70M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $4.19M derived: sum of 2 quarters · filed 2018-02-28 | $5.62M derived: sum of 3 quarters · filed 2018-02-28 | $10.40M 10-K · filed 2018-02-28 |
| 2015-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $3.88M derived: sum of 2 quarters · filed 2016-11-08 | $8.66M 10-Q · filed 2016-11-08 | $11.17M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $6.21M 10-Q · filed 2016-08-04 | $8.71M derived: sum of 3 quarters · filed 2017-02-28 | $11.44M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $4.78M 10-Q · filed 2016-05-05 | $7.29M derived: sum of 2 quarters · filed 2017-02-28 | $10.01M derived: sum of 3 quarters · filed 2017-02-28 | $12.60M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $5.23M derived: sum of 2 quarters · filed 2017-02-28 | $7.83M derived: sum of 3 quarters · filed 2017-02-28 | $21.39M 10-K · filed 2017-02-28 |
| 2014-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $5.32M derived: sum of 2 quarters · filed 2015-10-29 | $18.89M 10-Q · filed 2015-10-29 | $24.14M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $16.16M 10-Q · filed 2015-07-30 | $21.41M derived: sum of 3 quarters · filed 2016-02-25 | $27.93M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $13.57M 10-Q · filed 2015-05-01 | $18.82M derived: sum of 2 quarters · filed 2016-02-25 | $25.34M derived: sum of 3 quarters · filed 2016-02-25 | $32.93M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $11.77M derived: sum of 2 quarters · filed 2016-02-25 | $19.36M derived: sum of 3 quarters · filed 2016-02-25 | $27.10M 10-K · filed 2016-02-25 |
| 2013-09-30 | $6.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $14.11M derived: sum of 2 quarters · filed 2014-10-30 | $21.85M 10-Q · filed 2014-10-30 | $20.90M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $7.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $15.33M 10-Q · filed 2014-07-31 | $14.38M derived: sum of 3 quarters · filed 2015-02-26 | $15.77M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $7.74M 10-Q · filed 2014-05-01 | $6.79M derived: sum of 2 quarters · filed 2015-02-26 | $8.18M derived: sum of 3 quarters · filed 2015-02-26 | $16.88M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | -$953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $442.00K derived: sum of 2 quarters · filed 2015-02-26 | $9.14M derived: sum of 3 quarters · filed 2015-02-26 | $17.19M 10-K · filed 2015-02-26 |
| 2012-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $10.10M derived: sum of 2 quarters · filed 2013-11-01 | $18.14M 10-Q · filed 2013-11-01 | $23.54M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $16.75M 10-Q · filed 2013-08-02 | $22.15M derived: sum of 3 quarters · filed 2014-02-28 | $28.14M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $8.04M 10-Q · filed 2013-05-03 | $13.45M derived: sum of 2 quarters · filed 2014-02-28 | $19.43M derived: sum of 3 quarters · filed 2014-02-28 | |
| 2011-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $11.39M derived: sum of 2 quarters · filed 2014-02-28 | $11.39M 10-K · filed 2014-02-28 | |
| 2011-09-30 | $5.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.99M 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-02 | |||
| 2010-12-31 | $3.96M 10-K · filed 2013-03-01 | |||
| 2009-12-31 | -$637.00K 10-K · filed 2011-02-24 | |||
| 2008-12-31 | $144.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |